Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoCo3 contraceptive comparative health effects trial
2025-523359-71-00Phase 4Authorised
- Sponsor
- Pohjois-Pohjanmaan hyvinvointialue
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in contraception comparing Drovelis arm, Daylette arm and Slinda arm (3 arms). Primary endpoint: 12-month use of study preparation. Planned start Apr 2026; status: authorised.
02
Drugs
estetrolethinyl estradiol + drospirenonedrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on 2025-523359-71-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523359-71-00.